Ackerman Capital Advisors LLC Invests $374,000 in Colgate-Palmolive (CL)

Ackerman Capital Advisors LLC purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 5,050 shares of the company’s stock, valued at approximately $374,000.

Several other institutional investors and hedge funds have also modified their holdings of the company. Vanguard Group Inc. lifted its position in Colgate-Palmolive by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after buying an additional 1,621,392 shares during the last quarter. Renaissance Technologies LLC lifted its position in Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after buying an additional 2,903,800 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Colgate-Palmolive by 25.3% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after buying an additional 1,385,946 shares during the last quarter. First Eagle Investment Management LLC lifted its position in Colgate-Palmolive by 2.3% in the 2nd quarter. First Eagle Investment Management LLC now owns 4,891,131 shares of the company’s stock worth $362,580,000 after buying an additional 108,850 shares during the last quarter. Finally, TIAA CREF Investment Management LLC lifted its position in Colgate-Palmolive by 3.7% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 4,725,042 shares of the company’s stock worth $350,267,000 after buying an additional 170,053 shares during the last quarter. Hedge funds and other institutional investors own 72.96% of the company’s stock.

A number of analysts recently weighed in on CL shares. Jefferies Group restated a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research report on Thursday, August 24th. Macquarie started coverage on Colgate-Palmolive in a research report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price for the company. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, September 20th. Morgan Stanley upgraded Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $75.00 to $84.00 in a research report on Monday, September 25th. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Two research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have given a buy rating to the company’s stock. Colgate-Palmolive has an average rating of “Hold” and a consensus price target of $76.04.

In related news, COO Justin Skala sold 126,393 shares of the company’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $72.97, for a total value of $9,222,897.21. Following the sale, the chief operating officer now directly owns 262,361 shares of the company’s stock, valued at $19,144,482.17. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Victoria L. Dolan sold 9,000 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total value of $660,690.00. The disclosure for this sale can be found here. Insiders have sold 173,673 shares of company stock worth $12,629,293 over the last three months. Insiders own 1.02% of the company’s stock.

Shares of Colgate-Palmolive (NYSE:CL) opened at $74.59 on Wednesday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27. The firm has a market capitalization of $65,436.40, a P/E ratio of 25.97, a price-to-earnings-growth ratio of 3.41 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the previous year, the company posted $0.73 earnings per share. The business’s revenue was up 2.8% on a year-over-year basis. equities research analysts forecast that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were paid a dividend of $0.40 per share. The ex-dividend date was Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.15%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.

TRADEMARK VIOLATION NOTICE: “Ackerman Capital Advisors LLC Invests $374,000 in Colgate-Palmolive (CL)” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.com-unik.info/2017/12/06/ackerman-capital-advisors-llc-invests-374000-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

What are top analysts saying about Colgate-Palmolive? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit